2012
DOI: 10.1111/j.1440-1797.2012.01604.x
|View full text |Cite
|
Sign up to set email alerts
|

Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients

Abstract: These results demonstrate clinical evidence for an adverse effect of gastric acid suppression on the effectiveness of calcium carbonate phosphate binders. Given their frequent co-prescription, this interaction may be a minor but common reason why some patients fail to control hyperphosphataemia. Clinicians should regularly assess the need for acid suppressants. Further studies are needed to investigate interactions with other phosphate binders.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
14
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(15 citation statements)
references
References 41 publications
1
14
0
Order By: Relevance
“…CC bound more phosphate in acidic conditions, which is in concurrence with the previous literature, probably because of its optimum solubility in an acidic milieu . Similar effects were demonstrated with concomitant use of pantoprazole and CC in vivo where serum phosphate was higher in the group using both CC and pantoprazole …”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…CC bound more phosphate in acidic conditions, which is in concurrence with the previous literature, probably because of its optimum solubility in an acidic milieu . Similar effects were demonstrated with concomitant use of pantoprazole and CC in vivo where serum phosphate was higher in the group using both CC and pantoprazole …”
Section: Discussionsupporting
confidence: 90%
“…Clinically this may indicate a negative influence of a higher pH value on phosphate binding capacity. This has been demonstrated after ingestion of a meal, with proton pump inhibitor use, and in patients with chronic gastritis and hypochlorhydria, as frequently encountered in CKD . CA/MC bound more phosphate with baseline pH 6.0 and therefore the limitations mentioned above seem to be of lesser importance for CA/MC.…”
Section: Discussionmentioning
confidence: 92%
See 2 more Smart Citations
“…There is a concern that administration of these gastric acid reducers (ARs) may interfere with the phosphate binding effect of CaC [811]. The dissolution rate of tablet formulation of precipitated CaC is strongly pH dependent.…”
Section: Introductionmentioning
confidence: 99%